浏览全部资源
扫码关注微信
1. Department of Obstetrics and Gynecology, University of Oklahoma Health Science Center,OK,Oklahoma City,USA,73104
2. Department of Aging and Metabolism Research Program, Oklahoma Medical Research Foundation,OK,Oklahoma City,USA,73104
3. Department of Pathology, University of Oklahoma Health Science Center,OK,Oklahoma City,USA,73104
4. Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, California Northstate University, Elk Grove,CA,USA,95757
5. Department of Cell Biology, University of Oklahoma Health Science Center,OK,Oklahoma City,USA,73104
6. Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Science Center,OK,Oklahoma City,USA,73104
7. PTC Therapeutics, Inc, South Plainfield,NJ,USA,07080
纸质出版日期:2022,
网络出版日期:2022-11-1,
扫 描 看 全 文
Targeting BMI1 mitigates chemoresistance in ovarian cancer[J]. Genes & Diseases, 2022,9(6).
Anindya Dey, Shailendra Kumar Dhar Dwivedi, Lin Wang, et al. Targeting BMI1 mitigates chemoresistance in ovarian cancer[J]. Genes & Diseases, 2022,9(6).
Targeting BMI1 mitigates chemoresistance in ovarian cancer[J]. Genes & Diseases, 2022,9(6). DOI: 10.1016/j.gendis.2022.02.006.
Anindya Dey, Shailendra Kumar Dhar Dwivedi, Lin Wang, et al. Targeting BMI1 mitigates chemoresistance in ovarian cancer[J]. Genes & Diseases, 2022,9(6). DOI: 10.1016/j.gendis.2022.02.006.
0
浏览量
下载量
CSCD
关联资源
相关文章
相关作者
相关机构